(Q38471053)

3 September 2017

Measurement of complexed PSA improves specificity for early detection of prostate cancer (English)

1 reference

3 September 2017

1 reference

Brawer MK

1

1 reference

3 September 2017

Meyer GE

2

1 reference

3 September 2017

Letran JL

3

1 reference

3 September 2017

Bankson DD

4

1 reference

3 September 2017

Morris DL

5

1 reference

3 September 2017

Yeung KK

6

1 reference

3 September 2017

Allard WJ

7

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

3 September 2017

1 reference

3 September 2017

52

1 reference

3 September 2017

372-378

1 reference

3 September 2017

3

1 reference

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Screening for prostatic carcinoma with prostate specific antigen: results of the second year.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Analysis of variation in prostate-specific antigen values

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection Project

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Age-specific prostate-specific antigen: a reassessment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Multicenter comparison of the diagnostic performance of free prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Role of transrectal ultrasound and prostate biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Dual monoclonal antibody immunoassay for free prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Comparison of three commercial PSA assays: results of restandardization of the Ciba Corning method

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900241-6

7 January 2021

10.1016/S0090-4295(98)00241-6

Identifiers

DOI

1 reference

3 September 2017

1 reference